Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stereotaxis Inc (STXS)

Stereotaxis Inc (STXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 172,002
  • Shares Outstanding, K 84,730
  • Annual Sales, $ 26,770 K
  • Annual Income, $ -20,710 K
  • EBIT $ -22 M
  • EBITDA $ -22 M
  • 60-Month Beta 1.55
  • Price/Sales 6.49
  • Price/Cash Flow N/A
  • Price/Book 15.65

Options Overview Details

View History
  • Implied Volatility 88.88% ( -25.04%)
  • Historical Volatility 67.69%
  • IV Percentile 37%
  • IV Rank 9.92%
  • IV High 748.48% on 11/12/24
  • IV Low 16.21% on 09/16/24
  • Put/Call Vol Ratio 0.25
  • Today's Volume 50
  • Volume Avg (30-Day) 48
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 2,281
  • Open Int (30-Day) 3,916

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.06
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.82 +11.54%
on 11/08/24
2.27 -10.57%
on 11/13/24
+0.09 (+4.64%)
since 10/18/24
3-Month
1.82 +11.54%
on 11/08/24
2.46 -17.48%
on 08/26/24
+0.03 (+1.50%)
since 08/20/24
52-Week
1.50 +34.88%
on 11/22/23
3.29 -38.30%
on 04/05/24
+0.50 (+32.68%)
since 11/20/23

Most Recent Stories

More News
Stereotaxis Announces Successful Launch of Genesis Robotic Magnetic Navigation System at Hospital da Luz in Lisbon

Hospital da Luz in Portugal successfully treated patients using Stereotaxis' Genesis Robotic Magnetic Navigation System for cardiac procedures.Quiver AI SummaryStereotaxis has announced that the Hospital...

STXS : 2.03 (-0.98%)
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

STXS : 2.03 (-0.98%)
Stereotaxis Reports 2024 Third Quarter Financial Results

STXS : 2.03 (-0.98%)
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology

STXS : 2.03 (-0.98%)
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024

STXS : 2.03 (-0.98%)
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

STXS : 2.03 (-0.98%)
Stereotaxis (STXS) Q2 2022 Earnings Call Transcript

STXS earnings call for the period ending June 30, 2022.

STXS : 2.03 (-0.98%)
Stereotaxis Reports 2022 Second Quarter Financial Results

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.03 (-0.98%)
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline

ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.03 (-0.98%)
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022

ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.03 (-0.98%)

Business Summary

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires...

See More

Key Turning Points

3rd Resistance Point 2.10
2nd Resistance Point 2.08
1st Resistance Point 2.05
Last Price 2.03
1st Support Level 2.01
2nd Support Level 1.99
3rd Support Level 1.96

See More

52-Week High 3.29
Fibonacci 61.8% 2.61
Fibonacci 50% 2.40
Fibonacci 38.2% 2.19
Last Price 2.03
52-Week Low 1.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar